Crohn's disease

The study explores whether larger spleen size might play a causal role in the risk of ulcerative colitis or Crohn’s disease, using genetic data to reduce confounding. If a causal link exists, spleen volume could be a...

If approved, Tremfya SC induction could provide a fully subcutaneous induction and maintenance option for people with moderately to severely active ulcerative colitis, which may be more convenient than IV induction.

New Phase 2b data were presented for duvakitug, an investigational antibody for UC and Crohn’s disease; people with IBD may see this as a potential future treatment option if later trials are positive. The report focuses...

Cure8 found this source from rollingout.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for the...

This press release reports phase 2 evidence that a new experimental antibody (duvakitug) showed clinical, endoscopic, and histologic improvements in both UC and Crohn’s disease, which could lead to a new treatment option...

Cure8 found this source from hmpgloballearningnetwork.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Medications. Open the original article for the...

A new antibody, duvakitug, showed higher remission/response rates than placebo in Phase 2b study data for both ulcerative colitis and Crohn’s disease, which could lead to a new treatment option if Phase 3 trials confirm...

Cure8 found this source from newsmax.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Diet and lifestyle. Open the original article for the full details.

Cure8 found this source from hmpgloballearningnetwork.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Risankizumab. Open the original article for the...

People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help...

First-person stories from public figures can reduce stigma, show that people with Crohn's can continue their careers, and highlight practical coping strategies like diet, routines, and treatment adherence. Knowing about...

A new ustekinumab biosimilar (SELARSDI) is now available in the U.S. for Crohn’s disease and ulcerative colitis, which may expand treatment options and affect access or cost for patients on biologic therapy.

Local fundraising events raise money and visibility for people living with Crohn’s and colitis and can connect patients, families, and supporters. Participating or volunteering supports the charity and can offer social...

The study suggests a surgical change—removing the mesentery during Crohn’s operations—may significantly reduce early recurrence in the intestinal lining, which could mean fewer repeat surgeries and hospital readmissions...

Cure8 could only read part of this source from crainscleveland.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and...

This study maps what researchers have been publishing about Crohn's disease in children over the past decade, highlighting major topics, influential papers, and active authors/institutions.

Some people with Crohn’s have ongoing GI symptoms despite little visible inflammation. This study suggests the gut microbiome—particularly sulfur-producing bacteria—may be a reason, and diet could be a potential target...

The article summarizes a commercial market report that lists current and upcoming Crohn's disease treatments, trial results, and a biosimilar approval — information patients may see reflected in treatment availability,...

This is early-stage research about combining antibody targets (α4β7 and TL1A) for IBD; if validated in humans, combination biologics could offer improved effectiveness or dosing convenience.

Public recognition can raise awareness and reduce stigma around Crohn’s disease and IBD. Amy Dowden’s advocacy and fundraising may encourage more conversation, support, and attention to research and services that matter...

Based on the title and source metadata, this appears to be a patient education related to Crohn's disease and Community and awareness. The original article is from msn.com.

Cure8 found this source from chronicleonline.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Symptoms and flares. Open the original article for the full...

New oral TYK2 inhibitor data show promise on endoscopic healing and inflammatory markers in Crohn’s disease, which is important because oral treatment options are limited. However, the trial missed its main symptom-based...

This highlights public recognition of Crohn’s disease advocacy, which can raise awareness, reduce stigma, and support fundraising for care and research. Seeing a well-known person talk openly about living with Crohn’s...

A surgical technique (mesentery removal) reported in an international randomized trial lowered early endoscopic recurrence after Crohn’s surgery. If validated more widely, it could reduce repeat operations and hospital...

Arthralgia and other extraintestinal symptoms may signal higher risk of developing peripheral arthritis in people with Crohn disease. Recognizing early joint pain could prompt closer monitoring or earlier rheumatology...

Early Phase 2 data suggest VTX958 may improve endoscopic healing and lower inflammatory markers in Crohn’s disease, outcomes that matter for long-term disease control. The report also notes the trial missed its primary...

This highlights recognition of a public figure who has raised awareness and funds for IBD; such visibility can help reduce stigma and point people to resources. It does not report new treatments or clinical findings.

Public figures who talk openly about Crohn's disease can reduce stigma, raise awareness, and boost fundraising for research and patient support. Amy Dowden's MBE spotlights IBD in mainstream media, which may help others...

A well-known public figure with Crohn’s is being recognized for advocacy while sharing experiences that many with IBD may relate to—flare symptoms, impacts on daily life, and how major illnesses and treatments (like...

This reports Phase 2 clinical data for an oral TYK2 inhibitor (VTX958) in Crohn’s disease — a potential new oral treatment approach. The drug showed meaningful endoscopic improvements and reductions in inflammatory...

Based on the title and source metadata, this appears to be a basic science related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from msn.com.

Cure8 found this source from gut.bmj.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for the...

Faecal calprotectin from ileostomy output could provide a non-invasive way to detect small-bowel inflammation after surgery, helping to guide monitoring and reduce reliance on invasive tests for postoperative Crohn’s...

This announcement signals growing clinical and preclinical data for obefazimod, an investigational IBD drug; it includes a preclinical report on anti-fibrotic activity, a complication important in Crohn’s disease.

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease, Crohn's disease, and Diet and lifestyle. The original article is from msn.com.

Based on the title and source metadata, this appears to be a basic science related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from alphagalileo.org.

Based on the title and source metadata, this appears to be a basic science related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from miragenews.com.

Personal stories about living with Crohn's can help people feel less alone and highlight lifestyle approaches some patients use to manage symptoms. The piece may prompt questions about diet, nutritionist support, and...

Personal stories from people living with Crohn’s can reduce stigma and spotlight lifestyle approaches some people report using to manage symptoms. This may be encouraging or prompt questions about non-medication...

Personal stories show how Crohn’s can be missed, the kinds of symptoms that lead people to seek care, and that surgery and newer biologic drugs (Skyrizi) can be part of treatment. It may encourage readers to advocate for...

If you have IBD or are at risk for colorectal disease, clinicians at the conference highlighted that these conditions are being seen more often and that treatment approaches have shifted toward personalized medicine and...

Crohn’s disease can cause problems beyond the gut that affect bones, skin, eyes, liver, kidneys, joints, and mental health. Knowing these links helps patients and caregivers watch for symptoms and get coordinated care to...

Cure8 found this source from academic.oup.com, but the page could not be read reliably yet. It is tagged for Crohn's disease and Research and clinical trials. Open the original article for the full details.

Blood in stool can be a sign of Crohn’s-related complications (ulcers, fissures, fistulas) or other conditions; prompt evaluation can identify the cause and prevent anemia or serious complications. The article summarizes...

Personal experiences with diet and lifestyle are often of interest to people living with Crohn's disease. Celebrity stories can raise awareness and encourage conversations about self-management and support.

Cure8 found this source from onlinelibrary.wiley.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Fecal calprotectin. Open the original article for the...

The article reports rising colorectal disease and IBD rates and describes modern shifts in treatment—topics that can affect screening, treatment options, and specialist care access for people with IBD or colorectal...